The University of Geneva organises a three-day course, in person and online, on the international drug control regime and its consequences for public health and human rights, with a limited number of full scholarships.
Leading drug policy researchers reflect on the current evidence base, persistent gaps and priorities for future investigation, and policy responses amid rapidly evolving challenges.
Kankainen and Tammi draw on a recent regional conference to examine the growing importance of human rights, civic participation and democracy in Nordic drug policy debates.
The rapid expansion of Europe's cocaine markets highlights the limitations of supply-side enforcement and strains already insufficient health responses.
LEPH2026 will bring together law enforcement, public health, policy and research experts to explore approaches at the intersection of policing and public health, including on drug policy and harm reduction.
The conference will together people with lived and living experience, policymakers, service providers, and health and social care professionals to explore responses to drug-related deaths and harms.
Trimbos Institute hosts a webinar exploring how shifting geopolitical priorities in Europe are reshaping drug policy, public health and harm reduction services.
C-EHRN highlights shifting drug trends across Europe, noting the rising prevalence of polydrug use, potent synthetic substances, and the critical need for adapted harm reduction services.